<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="24364">Glyceryl</z:chebi> <z:chebi fb="0" ids="46936">nonivamide</z:chebi> (GLNVA), a vanilloid receptor (VR) <z:chebi fb="4" ids="48705">agonist</z:chebi>, has been reported to have calcitonin gene-related <z:chebi fb="7" ids="16670">peptide</z:chebi>-associated vasodilatation and to prevent <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>-induced <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the neuroprotective effects of GLNVA on activated microglia-like cell mediated- and proparkinsonian neurotoxin 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in human dopaminergic <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> SH-SY5Y cells </plain></SENT>
<SENT sid="2" pm="."><plain>In coculture conditions, we used <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS)-stimulated BV-2 cells as a model of activated microglia </plain></SENT>
<SENT sid="3" pm="."><plain>LPS-induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> was significantly inhibited by <z:chebi fb="0" ids="33079">diphenylene</z:chebi> <z:chebi fb="0" ids="50317">iodonium</z:chebi> (DPI), an inhibitor of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase </plain></SENT>
<SENT sid="4" pm="."><plain>However, capsazepine, the selective VR1 <z:chebi fb="68" ids="48706">antagonist</z:chebi>, did not block the neuroprotective effects of GLNVA </plain></SENT>
<SENT sid="5" pm="."><plain>GLNVA reduced LPS-activated microglia-mediated neuronal <z:hpo ids='HP_0011420'>death</z:hpo>, but it lacked protection in DPI-pretreated cultures </plain></SENT>
<SENT sid="6" pm="."><plain>GLNVA also decreased LPS activated microglia induced overexpression of neuronal nitric-<z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (nNOS) and <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 91 phagocyte oxidase (gp91(phox)) on SH-SY5Y cells </plain></SENT>
<SENT sid="7" pm="."><plain>Pretreatment of BV-2 cells with GLNVA diminished LPS-induced nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production, overexpression of inducible nitric-<z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS), and gp91(phox) and intracellular reactive oxygen species (iROS) </plain></SENT>
<SENT sid="8" pm="."><plain>GLNVA also reduced cyclooxygenase (COX)-2 expression, inhibitor of nuclear factor (NF)-kappaB (IkappaB)alpha/IkappaBbeta degradation, NF-kappaB activation, and the overproduction of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, interleukin (IL)-1beta, and <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> in BV-2 cells </plain></SENT>
<SENT sid="9" pm="."><plain>However, GLNVA augmented anti-inflammatory cytokine IL-10 production on LPS-stimulated BV-2 cells </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, in 6-OHDA-treated SH-SY5Y cells, GLNVA rescued the changes in condensed nuclear and apoptotic bodies, prevented the decrease in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential, and reduced cells <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>GLNVA also suppressed accumulation of iROS and up-regulated <z:chebi fb="4" ids="30413">heme</z:chebi> oxygenase-1 expression </plain></SENT>
<SENT sid="12" pm="."><plain>6-OHDA-induced overexpression of nNOS, iNOS, COX-2, and gp91(phox) was also reduced by GLNVA </plain></SENT>
<SENT sid="13" pm="."><plain>In summary, the neuroprotective effects of GLNVA are mediated, at least in part, by decreasing the <z:mp ids='MP_0001845'>inflammation</z:mp>- and <z:mp ids='MP_0003674'>oxidative stress</z:mp>-associated factors induced by microglia and 6-OHDA </plain></SENT>
</text></document>